FeedworthyAI
About RSSAI/GEO Feed Optimization
Sign InGet Started
Back to feed
BioPharma Dive - Latest NewsNews & Politicsnews

Boehringer dual-acting obesity shot hits mark in Phase 3 trial

Tuesday, April 28, 2026Jonathan GardnerView original

Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well.

Read the full article on the original site.

Read Full Article
Back to feedView original
FeedworthyAI·Privacy Policy·Terms of Service